Literature DB >> 20127491

Transient receptor potential channelopathies.

Bernd Nilius1, Grzegorz Owsianik.   

Abstract

In the past years, several hereditary diseases caused by defects in transient receptor potential channels (TRP) genes have been described. This review summarizes our current knowledge about TRP channelopathies and their possible pathomechanisms. Based on available genetic indications, we will also describe several putative pathological conditions in which (mal)function of TRP channels could be anticipated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127491     DOI: 10.1007/s00424-010-0788-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  177 in total

Review 1.  In vivo TRPC functions in the cardiopulmonary vasculature.

Authors:  Alexander Dietrich; Hermann Kalwa; Beate Fuchs; Friedrich Grimminger; Norbert Weissmann; Thomas Gudermann
Journal:  Cell Calcium       Date:  2007-04-11       Impact factor: 6.817

Review 2.  TRP channels entering the structural era.

Authors:  Rachelle Gaudet
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

Review 3.  TRP channels: a TR(I)P through a world of multifunctional cation channels.

Authors:  Bernd Nilius; Thomas Voets
Journal:  Pflugers Arch       Date:  2005-07-13       Impact factor: 3.657

4.  Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder.

Authors:  Chun Xu; Fabio Macciardi; Peter P Li; Il-Sang Yoon; Robert G Cooke; Bronwen Hughes; Sagar V Parikh; Roger S McIntyre; James L Kennedy; Jerry J Warsh
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

5.  The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1.

Authors:  Mohammad A Samie; Christian Grimm; Jeffrey A Evans; Cyntia Curcio-Morelli; Stefan Heller; Susan A Slaugenhaupt; Math P Cuajungco
Journal:  Pflugers Arch       Date:  2009-11       Impact factor: 3.657

6.  Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation.

Authors:  Yoshiro Suzuki; Andreas Pasch; Olivier Bonny; Markus G Mohaupt; Matthias A Hediger; Felix J Frey
Journal:  Hum Mol Genet       Date:  2008-02-13       Impact factor: 6.150

7.  The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx.

Authors:  Tao Na; Wei Zhang; Yi Jiang; Youyou Liang; He-Ping Ma; David G Warnock; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

8.  A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype.

Authors:  Hyun Jin Kim; Qin Li; Sandra Tjon-Kon-Sang; Insuk So; Kirill Kiselyov; Abigail A Soyombo; Shmuel Muallem
Journal:  EMBO J       Date:  2008-03-27       Impact factor: 11.598

9.  Store-operated Ca2+ channels formed by TRPC1, TRPC6 and Orai1 and non-store-operated channels formed by TRPC3 are involved in the regulation of NADPH oxidase in HL-60 granulocytes.

Authors:  S Bréchard; C Melchior; S Plançon; V Schenten; E J Tschirhart
Journal:  Cell Calcium       Date:  2008-04-23       Impact factor: 6.817

10.  Altered functional properties of a TRPM2 variant in Guamanian ALS and PD.

Authors:  Meredith C Hermosura; Aaron M Cui; Ramon Christopher V Go; Bennett Davenport; Cory M Shetler; Justin W Heizer; Carsten Schmitz; Gabor Mocz; Ralph M Garruto; Anne-Laure Perraud
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

View more
  70 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

3.  Orai1 determines calcium selectivity of an endogenous TRPC heterotetramer channel.

Authors:  Donna L Cioffi; Songwei Wu; Hairu Chen; Mikhail Alexeyev; Claudette M St Croix; Bruce R Pitt; Stefan Uhlig; Troy Stevens
Journal:  Circ Res       Date:  2012-04-24       Impact factor: 17.367

4.  The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin.

Authors:  Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Waybill; Kathleen Conrad; Kerry Keefer; Wenyi Zhang; Shu-jen Chen; Joseph Y Cheung; Barbara A Miller
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

Review 5.  TRP channels in the skin.

Authors:  Balázs I Tóth; Attila Oláh; Attila Gábor Szöllősi; Tamás Bíró
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

6.  Discrete control of TRPV4 channel function in the distal nephron by protein kinases A and C.

Authors:  Mykola Mamenko; Oleg L Zaika; Nabila Boukelmoune; Jonathan Berrout; Roger G O'Neil; Oleh Pochynyuk
Journal:  J Biol Chem       Date:  2013-05-24       Impact factor: 5.157

Review 7.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 8.  New insights into TRP channels: Interaction with pattern recognition receptors.

Authors:  Huirong Han; Fan Yi
Journal:  Channels (Austin)       Date:  2013-12-03       Impact factor: 2.581

9.  Intracellular ATP supports TRPV6 activity via lipid kinases and the generation of PtdIns(4,5) P₂.

Authors:  Eleonora Zakharian; Chike Cao; Tibor Rohacs
Journal:  FASEB J       Date:  2011-08-02       Impact factor: 5.191

Review 10.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.